Under the terms of the agreement, Kazia will receive an upfront payment of US$11million(~AU$ 14.2 million), comprising US$7 million in cash and a US$4 million equity investment,priced at a 20% premium to recent trading.
My estimate for the transaction relating to Simcere equity purchase of Kazia shares.
Average of last 7 days closing price Kazia - KZA = AU$1.416 @ 20% premium = Approx $1.70 per share.
US$4,000,000 @ 0.762 = AU$5,249,344.
Kazia issued shares - 3,087,850 @ $1.70.
Represents 2.38% of total Kazia shares.
Latest US trading price for KZIA US$12.90 @ 0.762 and divded by 10 = AU$1.693.
Regards.
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia licenses paxalisib to Simcere in Greater China
Ann: Kazia licenses paxalisib to Simcere in Greater China, page-29
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online